aod 9604
Regeneration vs degeneration — where this fits
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
What it is
2026 narrative review in Sports Med discussing AOD-9604 among other peptides, noting limited rigorous human data and safety concerns for unapproved use. 2026 review article covering AOD-9604 in orthopaedic context, referencing its original lipolytic investigation.
Why it would work (logic chain)
- IF 2026 narrative review in Sports Med discussing AOD-9604 among other peptides, noting limited rigorous human data and safety concerns for unapproved use. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF 2026 review article covering AOD-9604 in orthopaedic context, referencing its original lipolytic investigation. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
How many people take it
There is no reliable global count of how many people take this compound. That number is not in this ledger.
What we can count from this ledger:
- 0 anecdote source(s) (posts, threads, comments)
- 0 anecdote-tier claim(s) derived from them
Logic: Without catalogued Reddit/X posts, this article cannot answer how many people take it — only what studies exist.
Evidence inventory
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 2
- Claims tagged human evidence: 2
- Claims tagged preclinical (animal/lab): 0
- Claims tagged anecdotal: 0
- Reddit posts catalogued: 0
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 2
Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.
Quantified confidence (this ledger): 0.29 / 1.00 — low — animal and anecdote heavy
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance (source s1)
2026 narrative review in Sports Med discussing AOD-9604 among other peptides, noting limited rigorous human data and safety concerns for unapproved use.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions (source s2)
2026 review article covering AOD-9604 in orthopaedic context, referencing its original lipolytic investigation.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Evidence ledger 2 · tier-ranked · API
Ask this article · 4 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.